Hound Partners’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-25,000	Closed	-$989K	–	117
2021 Q3	$989K	Buy	+25,000	New	+$989K	0.05%	139